U.S. markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
140.36-0.34 (-0.24%)
At close: 4:00PM EDT
140.36 0.00 (0.00%)
After hours: 04:44PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close140.70
Bid137.55 x 800
Ask143.11 x 800
Day's Range138.85 - 140.69
52 Week Range126.01 - 189.00
Avg. Volume725,235
Market Cap8.613B
Beta (5Y Monthly)0.95
PE Ratio (TTM)204.01
EPS (TTM)0.69
Earnings DateNov 01, 2021 - Nov 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est205.47
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-21% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for JAZZ

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Jazz Pharmaceuticals plc
    JAZZ: Raising target price to $149.00JAZZ PHARMACEUTICALS PLC has an Investment Rating of BUY; a target price of $149.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    12 days agoArgus Research
View more
  • Zacks

    How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

    Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

  • Insider Monkey

    Hedge Funds Are Cashing Out Of Jazz Pharmaceuticals Plc (JAZZ)

    Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. In the following paragraphs, we find out […]

  • Motley Fool

    September Sell-Off: 3 Dirt Cheap Growth Stocks to Buy

    September's been a rough month for the stock market, and on Monday, the S&P 500 had its worst day in months, falling 1.7%. Instead, it may be time to load up on three growth stocks near their 52-week lows, including Jazz Pharmaceuticals (NASDAQ: JAZZ), Activision Blizzard (NASDAQ: ATVI), and Alibaba Group Holding (NYSE: BABA). Healthcare company Jazz Pharmaceuticals is trading at around $130 and has been falling more than 20% year to date, while the S&P 500 has risen by 16%.